Toggle menu

BRAINED Study

Start date:
April 2018
End date:
August 2020
Co-ordinated by:
Neurosurgery Department, Western General Hospital, Edinburgh
Main trial site:
RIE & Western General Hospital, Edinburgh

 

Blood samples will be assessed using infrared spectroscopy as part of a project looking at tumour biomarkers to ascertain whether people most at risk of having a brain tumour can be correctly identified.

This is a tissue governance project aiming to recruit 600 participants in order to inform a larger trial.

Chief Investigator

Mr Paul Brennan

Consultant Neurosurgeon

Local PI

Dr Matt Reed

Director of EMERGE, Consultant, NRS Career Research Fellow & Honorary Reader in Emergency Medicine

Research Team

Rachel O'Brien

Lead Research Nurse

Clare Moceivei

Senior Research Nurse

Allan MacRaild

Stroke Lead Research Nurse

Jessica Teasdale

Senior Research Nurse - Stroke/Neurosurgery

Michelle Curtin

Senior Research Nurse - Stroke/Neurosurgery

More EMERGE Trials

TARGET CTCA is a joint venture between EMERGE and the cardiology research team aiming to recruit patients with suspected ACS across NHS Lothian and NHS Greater Glasgow and Clyde. The study aims to recruit 2270 participants. For further information, please contact the EMERGE team.

Read more

TARGET-CTCA Trial

DASH Trial

DASH is a randomised clinical trial investigating a treatment to reverse the effects of blood-thinning medications.

This is a study looking at incidence and risk factors for poor ankle functional recovery, and the development and progression of post-traumatic ankle osteoarthritis after significant ankle ligament injury.

Read more

SALI Study

SALI study - Significant Ankle Ligament Injury